Skip to main content


Fig. 1 | BMC Ophthalmology

Fig. 1

From: Mydriasert pupillary dilation for cataract surgery: an economic and clinical study

Fig. 1

Budget impact model structure. The model follows a cohort of patients, and calculates the drug, consumable and staff costs for achieving mydriasis using Mydriasert and eye drops (tropicamide [1 %] and phenylephrine [10 %]). The structure of the analysis aimed to incorporate all costs and outcomes relevant to the NHS and to capture any significant differences in costs between treatments

Back to article page